1. Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis.

Brain, 2022

Riva, N., Gentile, F., Cerri, F., (…), Corbo, M., Filippi, M., Quattrini, A.

2. Predicting home discharge after inpatient rehabilitation of stroke patients with aphasia.

Neuropsychological Rehabilitation, 2022

Ginex, V., Viganò, M., Gilardone, G., Monti, A., Gilardone, M., Corbo, M.

3. An overview of the therapeutic effects of curcumin in reproductive disorders with a focus on the antiinflammatory and immunomodulatory activities.

Phytotherapy Research, 2022

Saifi, B., Haftcheshmeh, S.M., Feligioni, M., (…), Mohammadi, A., Sahebkar, A.

4. Brain Connectivity and Graph Theory Analysis in Alzheimer’s and Parkinson’s Disease: The Contribution of Electrophysiological Techniques.

Brain Sciences, 2022

Miraglia, F., Vecchio, F., Pappalettera, C., (…), Judica, E., Ferreri, F., Rossini, P.M.

5. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.

Nature Genetics, 2022

van Rheenen W., van der Spek R.A.A., Bakker M.K., (…), SLALOM Consortium, PARALS Consortium, SLAGEN Consortium, SLAP Consortium

6. Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoder.

Pattern Recognition, 2022

Liu, S., Han, J., Puyal, E.L., ( …), Comi, G., Schuller, B., Consortium, R.A.D.A.R.-C.N.S.

7. Molecular and clinical implications of variant repeats in myotonic dystrophy type 1.

International Journal of Molecular Sciences, 2022

Peric, S., Pesovic, J., Savic-Pavicevic, D., Stojanovic, V.R., Meola, G.

8. Patient Perception When Transitioning from Classic to Remote Assisted Cardiac Rehabilitation

Diagnostics, 2022

Busnatu, Ș.-S., Pană, M.-A., Lăcraru, A.E., Caprino, M.; (…), Andrei, C.L., Sinescu, C.-J.

9. Improving reproducibility of motor evoked potentials in mice

Journal of Neuroscience Methods, 2022

Castoldi, V., Rossi, E., Marenna, S., Comi, G., Leocani, L.

10. Intensive Neurorehabilitation and Gait Improvement in Progressive Multiple Sclerosis: Clinical, Kinematic and Electromyographic Analysis

Brain Sciences, 2022

Huang, S.-C., Guerrieri, S., Costa, G.D., (…), Comi, G., Leocani, L.

11. Dose-dependent effect of myelin oligodendrocyte glycoprotein on visual function and optic nerve damage in experimental autoimmune encephalomyelitis

Journal of Neuroscience Research, 2022

Castoldi, V., Marenna, S., Huang, S.-C., (…), Comi, G., Leocani, L.

12. Cross-cultural adaptation into Italian and validation of the Frenchay dysarthria assessment – 2

European Journal of Physical and Rehabilitation Medicine, 2022

Riolo V., Pizzorni N., Guanziroli E., Agostinis B., Confortola M., Schettino N., Gilardone G., Schindler A., Molteni F.

13. One-year cognitive follow-up of COVID-19 hospitalized patients

European Journal of Neurology, 2022

Ferrucci, R., Dini, M., Rosci, C., (…), Monti, A., Ticozzi N., Silani, V., Centanni, S., D’Arminio Monforte, A., Tagliabue, L., Priori, A.

14. Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial

European Journal of Neurology, 2022

Vermersch, P., Oreja-Guevara, C., Siva, A., (…), Kuenzel, T., Comi, G.

15. Acid-Base Disorders in COVID-19 Patients with Acute Respiratory Distress Syndrome

Journal of Clinical Medicine, 2022

Chiumello, D., Pozzi, T., Fratti, I., (…), Papa, G.F.S., Coppola, S.

16. Performance prediction in a visuo-motor task: the contribution of EEG analysis

Cognitive Neurodynamics, 2022

Vecchio, F., Alù, F., Orticoni, A., (…), Judica, E., Cotelli, M., Rossini, P.M.

17. Visual Evoked Potentials to Monitor Myelin Cuprizone-Induced Functional Changes

Frontiers in Neuroscience, 2022

Marenna S., Huang S.-C., Dalla Costa G., d’Isa R., Castoldi V., Rossi E., Comi G., Leocani L.

18. Role of hyperpnea in the relaxant effect of inspired CO2 on methacholine-induced bronchoconstriction

Journal of Applied Physiology, 2022

Torchio R., Gobbi A., Gulotta C., Antonelli A., Dellacà R., Pellegrino G.M., Pellegrino R., Brusasco V.

19. Role of hyperpnea in the relaxant effect of inspired CO2 on methacholine-induced bronchoconstriction

Multiple Sclerosis and Related Disorders, 2022

Zaratin, P., Vermersch, P., Amato, M.P., (…), Baneke, P., Comi, G.

20. Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2

Frontiers in Neurology, 2022

Peric, S., Zlatar, J., Nikolic, L., (…), Meola, G., Rakocevic-Stojanovic, V.

21. Case report: Sodium and chloride muscle channelopathy coexistence: A complicated phenotype and a challenging diagnosis

Frontiers in Neurology, 2022

Pagliarani, S., Meola, G., Filareti, M., Comi, G.P., Lucchiari, S.

22. The Reaching Phase of Feeding and Self-Care Actions Optimizes Action Observation Effects in Chronic Stroke Subjects

Neurorehabilitation and Neural Repair, 2022

Franceschini M., Ottaviani M., Romano P., Goffredo M., Pournajaf S., Lofrumento M., Proietti S., Sterpi I., Tricomi E., Tropea P., Corbo M., Fadiga L., Infarinato F.

23. A phase I/IIa clinical trial of autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis

Journal of Neurology, 2022

Lunetta C., Lizio A., Cabona C., Gerardi F., Sansone V.A., Corbo M., Scialò C., Angelucci E., Gualandi F., Marenco P., Grillo G., Cairoli R., Cesana C., Saccardi R., Melazzini M.G., Mancardi G., Caponnetto C.

24. Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol

PLoS ONE, 2022

Mikolaizak A.S., Rochester L., Maetzler W., (…) Comi G., Leocani L., Helbostad J.L., Johnsen L.G., Taraldsen K., Blain H., Driss V., Frei A., Puhan M.A., Polhemus A., de Basea M.B., Gimeno E., Hopkinson N.S., Buttery S.C., Hausdorff J.M., Mirelman A., Evers J., Neatrour I., Singleton D., Schwickert L., Becker C., Jansen C.-P., (WP4) on behalf of Mobilise-D consortium

25. Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial

Multiple Sclerosis Journal, 2022

Cree B.A.C., Selmaj K.W., Steinman L., Comi G., Bar-Or A., Arnold D.L., Hartung H.-P., Montalbán X., Havrdová E.K., Sheffield J.K., Minton N., Cheng C.-Y., Silva D., Kappos L., Cohen J.A.

26. A Plasma Circular RNA Profile Differentiates Subjects with Alzheimer’s Disease and Mild Cognitive Impairment from Healthy Controls

International Journal of Molecular Sciences, 2022

Piscopo P., Manzini V., Rivabene R., Crestini A., Le Pera L., Pizzi E., Veroni C., Talarico G., Peconi M., Castellano A.E., D’Alessio C., Bruno G., Corbo M., Vanacore N., Lacorte E.,

27. A systematic review on drugs for synaptic plasticity in the treatment of dementia

Ageing Research Reviews, 2022

Piscopo P., Crestini A., Carbone E., Rivabene R., Ancidoni A., Lo Giudice M., Corbo M., Vanacore N., Lacorte E.,

28. Costs and effects of telerehabilitation in neurological and cardiological diseases: A systematic review

Frontiers in Medicine, 2022

Del Pino, R., Díez-Cirarda, M., Ustarroz-Aguirre, I., (…), Caprino, M., Gabilondo, I., Gómez-Esteban, J.C.

29. Electroencephalographic hallmarks of Alzheimer’s disease

International Journal of Psychophysiology, 2022

Ferreri F., Miraglia F., Vecchio F., Manzo N., Cotelli M., Judica E., Rossini P.M.

30. End Users’ and Other Stakeholders’ Needs and Requirements in the Development of a Personalized Integrated Care Platform (PROCare4Life) for Older People With Dementia or Parkinson Disease: Mixed Methods Study

JMIR Formative Research, 2022

Ahmed, M., Marín, M., Judica, E., Tropea, P., (….), Bouça-Machado, R., Brach, M.

31. Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study

Neurological Sciences, 2022

Baroncini D., Ghezzi A., Guaschino C., (…), Comi G., Zaffaroni M., Trojano M., Centonze D., Capra R., Capobianco M., Laroni A., Uccelli A., Gallo A., Patti F., Danni M.C., Gasperini C., Coniglio G., MS Study Group of the Italian Neurological Society

32. Semiology and determinants of apathy across neurodegenerative motor disorders: A comparison between amyotrophic lateral sclerosis, Parkinson’s and Huntington’s disease

Frontiers in Aging Neuroscience, 2022

Poletti B., Solca F., Maffi S., Torre S., Carelli L., Aiello E.N., Ferrucci R., Priori A., Monti A., Verde F., Ticozzi N., Migliore S., Scaricamazza E., Casella M., Squitieri F., Ciammola A., Silani V.

33. Transcranial direct current stimulation as a preventive treatment in multiple sclerosis? Preclinical evidence

Experimental Neurology, 2022

Marenna S., Huang S.-C., Rossi E., Castoldi V., Comi G., Leocani L.,

34. A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes

Neurological Sciences, 2022

Bellomo G., Piscopo P., Corbo M., Pupillo E., Stipa G., Beghi E., Vanacore N., Lacorte E.,

35. Anterior optic pathway pathology in CNS demyelinating diseases

Brain , 2022

Pisa, M., Pansieri, J., Yee, S., …Leocani, L., DeLuca, G.Comi

36. Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis

Journal of Clinical Medicine, 2022

Siddi S., Giné-Vázquez I., Bailon R., Matcham F., Lamers F., Kontaxis S., Laporta E., Garcia E., Arranz B., Dalla Costa G., Guerrero A.I., Zabalza A., Buron M.D., Comi G., Leocani L., (…), Myin-Germeys I., Haro J.M., PAB Members, on behalf of the RADAR-CNS Consortium

37. Cell environment shapes TDP-43 function with implications in neuronal and muscle disease

Communications Biology, 2022

Šušnjar, U., Škrabar, N., Brown, A.-L., (…), Meola, G., Ripolone M., Moggio, M., Secrier, M., Fratta, P., Buratti, E.

38. New Insights into Dose-Dependent Effects of Curcumin on ARPE-19 Cells

International Journal of Molecular Sciences, 2022

Carozza G., Tisi A., Capozzo A., Cinque B., Giovannelli A., Feligioni M., Flati V., Maccarone R.,

39. Syntaxin-1a and SNAP-25 expression level is increased in the blood samples of ischemic stroke patients

Scientific Reports, 2022

Cappelletti P., Filareti M., Masuelli L., Bei R., Hassanzadeh K., Corbo M., Feligioni M.

40. The utility of wearable devices in assessing ambulatory impairments of people with multiple sclerosis in free-living conditions

Computer Methods and Programs in Biomedicine, 2022

Sun S., Folarin A.A., Zhang Y., Cummins N., Liu S., (…), Comi G., Dobson R.J., RADAR-CNS consortium

41. Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register

Multiple Sclerosis Journal, 2022

Iaffaldano P., Lucisano G., Guerra T., (…), Comi G., Filippi M., Amato M.P., Trojano M.,

42. Disease stability over five years in people with multiple sclerosis treated with cladribine tablets: a plain language summary of publication

Neurodegenerative Disease Management, 2022

Giovannoni, G., Comi, G., Rammohan, K., (…), Jack, D., Vermersch, P.

43. Signs and symptoms of COVID-19 in patients with multiple sclerosis

European Journal of Neurology, 2022

Schiavetti, I., Carmisciano, L., Ponzano, M., (…), Comi, G., Zito, A., Zuliani, L.

44. Ofatumumab subcutaneous injection for the treatment of relapsing forms of multiple sclerosis

Expert Review of Clinical Immunology., 2022

Dalla Costa, G., Leocani, L., Comi, G.

45. Post-stroke acquired childhood aphasia. A scoping review

Child Neuropsychology, 2022

Gilardone, G., Viganò, M., Cassinelli, D., (…), Sozzi, M., Corbo, M.

46. Protective Effect of Curcuma Extract in an Ex Vivo Model of Retinal Degeneration via Antioxidant Activity and Targeting the SUMOylation

Oxidative medicine and cellular longevity, 2022

Hassanzadeh K., Vahabzadeh Z., Bucarello L., Dragotto J., Corbo M., Maccarone R., Feligioni M.

47. Reliable change indices for the Italian Edinburgh Cognitive and Behavioral ALS Screen (ECAS)

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2022

Aiello E.N., Solca F., Torre S., Carelli L., Monti A., Ferrucci R., Verde F., Ticozzi N., Silani V., Poletti B.,

48. Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials

Journal of Alzheimer’s Disease, 2022

Lacorte E., Ancidoni A., Zaccaria V., Remoli G., Tariciotti L., Bellomo G., Sciancalepore F., Corbo M., Lombardo F.L., Bacigalupo I., Canevelli M., Piscopo P., Vanacore N.,

49. Let Time Teach You: A Case Report of a Double Diagnosis of 17P Duplication and Ehlers-Danlos Syndrome

Genes, 2022

Castronovo, P., Aleo, S., Seresini, A., Brunati, E., (…), Guez, S., Milani, D.

50. The Italian Aphasia Awareness Survey (IAAS): an online questionnaire about the public knowledge of aphasia in Italy, informative findings

Aphasiology, 2022

Viganò, M., Gilardone, G., Cassinelli, D., (…), Corbo, M., Monti, A.

51. Clinical score for early diagnosis of myotonic dystrophy type 2

Neurological Sciences, 2022

Ivanovic, V., Peric, S., Pesovic, J., (…), Meola, G., Rakocevic-Stojanovic, V.

52. Prevalence and determinants of language impairment in non-demented amyotrophic lateral sclerosis patients

European Journal of Neurology, 2022

Solca, F., Aiello, E.N., Torre, S., (…), Monti, A., Poletti, B.

53. The Semantic Association Test (SAT): normative data from healthy Italian participants and a validation study in aphasic patients

Neurological Sciences, 2022

Banco, E., Veronelli, L., Briguglio, M., Luzzatti, C., Vallar, G.

54. AGREE: an upper-limb robotic platform for personalized rehabilitation, concept and clinical study design

IEEE International Conference on Rehabilitation Robotics, 2022

Gasperina S.D., Longatelli V., Panzenbeck M., Luciani B., Morosini A., Piantoni A., Tropea P., Braghin F., Pedrocchi A., Gandolla M.

55. Editorial: Neurodegeneration: From Disease Mechanism to Therapeutic Advancement

Frontiers in Genetics, 2022

Sarkar, P.S., Meola, G., Zhang, N.

56. Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β

Multiple Sclerosis and Related Disorders, 2022

Simpson-Yap, S., Pirmani, A., De Brouwer, E., (…), Comi, G., Kalincik, T.

57. Emerging trends in multiple sclerosis research

Multiple Sclerosis and Related Disorders, 2022

Dalla Costa G., Comi G.

58. Synaptosomal Preparation and Its Application in Preclinical Studies

Neuromethods, 2022

Feligioni M., Buccarello L., Hassanzadeh K., Corbo M.